Lv51
1210 积分 2023-12-20 加入
T-cell-engaging bispecific antibodies in cancer
1个月前
已完结
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review
2个月前
已完结
43019 Spesolimab for hidradenitis suppurativa: A proof-of-concept study
2个月前
已完结
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
2个月前
已完结
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses
2个月前
已完结
The immunology of systemic lupus erythematosus
2个月前
已完结
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses
2个月前
已完结
T cell-engaging therapies — BiTEs and beyond
3个月前
已完结
Vitiligo
3个月前
已完结
STAR particles for enhanced topical drug and vaccine delivery
4个月前
已完结
皖公网安备34019202002308
